Safa , Norton C
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338372
PMC: 11434643.
DOI: 10.3390/ph17091210.
Yanev P, Martin-Jimenez C, Vesga-Jimenez D, Zvinys L, Weinrich N, Cree M
J Cereb Blood Flow Metab. 2024; 45(1):102-114.
PMID: 39113414
PMC: 11572231.
DOI: 10.1177/0271678X241270445.
Angelucci F, Veverova K, Katonova A, Vyhnalek M, Hort J
ACS Omega. 2023; 8(39):36025-36031.
PMID: 37810633
PMC: 10552510.
DOI: 10.1021/acsomega.3c04076.
Mennesson M, Revest J
Int J Mol Sci. 2023; 24(5).
PMID: 36901924
PMC: 10003592.
DOI: 10.3390/ijms24054496.
Lee S, Shin C, Ko Y, Lee M, Park M, Pae C
Clin Psychopharmacol Neurosci. 2023; 21(1):147-161.
PMID: 36700321
PMC: 9889913.
DOI: 10.9758/cpn.2023.21.1.147.
Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
Eruysal E, Ravdin L, Zhang C, Kamel H, Iadecola C, Ishii M
J Alzheimers Dis. 2022; 91(3):1073-1083.
PMID: 36565112
PMC: 10518184.
DOI: 10.3233/JAD-220686.
Alzheimer's Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis.
Angelucci F, Veverova K, Katonova A, Piendel L, Vyhnalek M, Hort J
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145295
PMC: 9505552.
DOI: 10.3390/ph15091074.
The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?.
Zhu J, Wan Y, Xu H, Wu Y, Hu B, Jin H
Cell Mol Life Sci. 2019; 76(8):1489-1506.
PMID: 30656378
PMC: 11105644.
DOI: 10.1007/s00018-019-03005-8.
Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications.
Angelucci F, Cechova K, Prusa R, Hort J
CNS Neurosci Ther. 2018; 25(3):303-313.
PMID: 30403004
PMC: 6488905.
DOI: 10.1111/cns.13082.
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.
Bennett R, Robbins A, Hu M, Cao X, Betensky R, Clark T
Proc Natl Acad Sci U S A. 2018; 115(6):E1289-E1298.
PMID: 29358399
PMC: 5819390.
DOI: 10.1073/pnas.1710329115.
The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer's Disease.
Fekih-Mrissa N, Mansour M, Sayeh A, Bedoui I, Mrad M, Riahi A
Am J Alzheimers Dis Other Demen. 2017; 32(6):342-346.
PMID: 28466654
PMC: 10852582.
DOI: 10.1177/1533317517705223.
Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies.
Jiang H, Li X, Chen S, Lu N, Yue Y, Liang J
Sci Rep. 2016; 6:30464.
PMID: 27456456
PMC: 4960524.
DOI: 10.1038/srep30464.
Dysfunction in the coagulation system and schizophrenia.
Hoirisch-Clapauch S, Amaral O, Mezzasalma M, Panizzutti R, Nardi A
Transl Psychiatry. 2016; 6:e704.
PMID: 26731441
PMC: 5068878.
DOI: 10.1038/tp.2015.204.
The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes.
Ko H, Lee S, Kim K, Joo S, Choi W, Shin C
Mol Neurobiol. 2014; 52(1):8-25.
PMID: 25106729
DOI: 10.1007/s12035-014-8837-z.
Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease.
Kutz S, Higgins C, Higgins P
Mol Med Ther. 2013; 1(2):106.
PMID: 23847772
PMC: 3703665.
DOI: 10.4172/2324-8769.1000106.
Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.
Ferrucci A, Nonnemacher M, Wigdahl B
J Neurovirol. 2013; 19(3):239-53.
PMID: 23728617
PMC: 3709860.
DOI: 10.1007/s13365-013-0170-1.
Beta-amyloidolysis and glutathione in Alzheimer's disease.
Lasierra-Cirujeda J, Coronel P, Aza M, Gimeno M
J Blood Med. 2013; 4:31-8.
PMID: 23650462
PMC: 3640603.
DOI: 10.2147/JBM.S35496.
Activators and inhibitors of the plasminogen system in Alzheimer's disease.
Barker R, Kehoe P, Love S
J Cell Mol Med. 2011; 16(4):865-76.
PMID: 21790972
PMC: 3822855.
DOI: 10.1111/j.1582-4934.2011.01394.x.
Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study.
Huotari A, Lehto S, Niskanen L, Herzig K, Hintikka J, Koivumaa-Honkanen H
Cardiovasc Psychiatry Neurol. 2010; 2010:501349.
PMID: 20300596
PMC: 2838223.
DOI: 10.1155/2010/501349.
Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.
Xin H, Li Y, Shen L, Liu X, Wang X, Zhang J
PLoS One. 2010; 5(2):e9027.
PMID: 20140248
PMC: 2815778.
DOI: 10.1371/journal.pone.0009027.